COMMUNIQUÉS West-GlobeNewswire

Opiant Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results and Provides Corporate Update
08/05/2018
SANTA MONICA, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT ), a specialty pharmaceutical company developing pharmacological treatments for addictions, today reported [...]
miRagen Therapeutics Announces New Interim Data From Phase 1 Clinical Trial of Cobomarsen in Mycosis Fungoides
08/05/2018
Treatment resulted in durable improved quality of life Cobomarsen continued to be generally well tolerated at all dose levels evaluated Advancing into a Phase 2 clinical trial in second half of 2018 BOULDER, Colo., May [...]
Zafgen Reports First Quarter 2018 Operating and Financial Results
08/05/2018
Multiple ZGN-1061 abstracts accepted for presentation at upcoming American Diabetes Association (ADA) Scientific Sessions ZGN-1061 Phase 1 SAD / MAD data published in Diabetes, Obesity and Metabolism BOSTON, May 08, [...]
R1 Closes Acquisition of Intermedix Corporation
08/05/2018
Management team focused on customer care and a methodical integration CHICAGO, May 08, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc . (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management (RCM) [...]
OncoMed Announces First Quarter 2018 Financial Results and Operational Highlights
08/05/2018
Q1 Cash Balance of $88.4 Million—Cash through Q3 2019 First patient expected to be dosed in Phase 1b portion of anti-TIGIT trial in second quarter of 2018 Navicixizumab data expected in second half of 2018 REDWOOD CITY [...]
OPKO Health Reports First Quarter 2018 Financial Results
08/05/2018
Conference Call begins today at 4:30 p.m. Eastern Time MIAMI, May 08, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK ) reports financial results and business highlights for the three months ended March 31, 2018 [...]
Kura Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update
08/05/2018
– Registration-directed trial of tipifarnib in HRAS mutant head and neck squamous cell carcinomas (HNSCC) on track to initiate in second half of 2018 – – Data from multiple Phase 2 trials of tipifarnib in solid tumor [...]
AGTC Announces Financial Results and Business Update for the Quarter Ended March 31, 2018
08/05/2018
GAINESVILLE, Fla. and CAMBRIDGE, Mass., May 08, 2018 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC ), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV [...]
Cutera Reports First Quarter 2018 Financial Results
08/05/2018
First Quarter Revenue of $34.1 Million; Increases 16% Year-over-Year North America System Revenue Grew 31% in the First Quarter BRISBANE, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Cutera, Inc. (NASDAQ: CUTR ) (“Cutera” [...]
VIVUS Reports First Quarter 2018 Financial Results
08/05/2018
Company provides business update on PANCREAZE ® acquisition, new Athyrium debt line and new management Company to host conference call today at 4:30pm ET CAMPBELL, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. ( [...]
Zosano Pharma to Host Conference Call on First Quarter 2018 Financial Results and Provide Operational Update
08/05/2018
FREMONT, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ: ZSAN ) (“Zosano” or the “Company”) a clinical-stage biopharmaceutical company focused on providing rapid systemic administration of [...]
Tabula Rasa HealthCare Announces First Quarter 2018 Operating Results
08/05/2018
First Quarter 2018 Revenue of $43.9 million, growth of 57%; 2018 Revenue Guidance Increased MOORESTOWN, N.J., May 08, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC ), a healthcare [...]
OpGen Reports First Quarter 2018 Financial Results and Provides a Business Update
08/05/2018
Revenue increases 10% to $0.8 million, net loss decreases 39% to $3.0 million Conference call begins at 4:30 p.m. Eastern time today GAITHERSBURG, Md., May 08, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) today [...]
Dynavax Reports First Quarter 2018 Financial Results
08/05/2018
Update on Initial Progress of HEPLISAV-B ® Commercial Launch Conference Call to be Held at 4:30pm ET/1:30pm PT BERKELEY, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) today [...]
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/05/2018
MENLO PARK, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
Xenon Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update
08/05/2018
Xenon’s novel clinical stage epilepsy candidates, XEN1101 and XEN901, to be presented at upcoming 14th Eilat Conference on New Antiepileptic Drugs and Devices on May 15, 2018 BURNABY, British Columbia, May 08, 2018 ( [...]
INSYS Therapeutics Announces Exclusive License Partnership with Lunatus to Commercialize SUBSYS® (fentanyl sublingual spray) in the Middle East
08/05/2018
PHOENIX, May 08, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, announced today [...]
Bellicum Pharmaceuticals Reports First Quarter 2018 Financial Results
08/05/2018
HOUSTON, May 08, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM ), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]
Gemphire Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
08/05/2018
LIVONIA, Mich., May 08, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, [...]

Pages